Contrast enhanced spectral mammography (CESM)

DIAGNOSTIC_TEST2 trials

Sponsors

Memorial Sloan Kettering Cancer Center, The Leeds Teaching Hospitals NHS Trust

Conditions

Breast AbnormalitiesMammography

Unknown Phase

Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities

CompletedNCT02406274

Memorial Sloan Kettering Cancer CenterBreast Abnormalities

Start: 2015-03-31End: 2024-06-27Updated: 2024-06-28

Can Contrast Enhanced Spectral Mammography (CESM) Reduce the Number of Benign Biopsies for Calcifications Without Negatively Impacting on Detection/Diagnosis of Clinically Significant Calcifications

The Leeds Teaching Hospitals NHS TrustMammography

Start: 2018-12-03End: 2021-02-02Target: 250Updated: 2019-02-27